An attenuated strain (263) of the tick-borne encephalitis virus, isolated from field ticks, was either serially subcultured, 5 times in mice, or at 40°C in PS cells, producing 2 independent strains, 263-m5 and 263-TR with identical genomes; both strains exhibited increased plaque size, neuroinvasiveness and temperature-resistance. Sequencing revealed two unique amino acid substitutions, one mapping close to the catalytic site of the viral protease. These observations imply that virus adaptation from ticks to mammals occurs by selection of pre-existing virulent variants from the quasispecies population rather than by the emergence of new random mutations. The significance of these observations is discussed.
Introduction
Tick-borne encephalitis (TBE) is the most important arbovirus neuroinfection in Europe and Asia (Gritsun et al., 2003) . It is caused by Tick-borne encephalitis virus (TBEV), a member of the genus Flavivirus within the family Flaviviridae (Thiel et al., 2005) . In the Czech Republic, the incidence of TBE is one of the highest in Europe, with 400-1,000 clinical cases annually (according to data from EpiDat, www.szu.cz). However, serological surveys of the population in the southern region of the Czech Republic have revealed high seroprevalance with little clinical evidence of infection (Kopecký et al., 1991; Luňáčková et al., 2003) . Thus, TBEV appears to infect a high proportion of humans relatively harmlessly and this needs to be explained. The virions are spherical particles, approximately 50 nm in diameter with a nucleocapsid composed of a (+) ssRNA genome enclosed in a capsid (C) protein and surrounded by a host cell-derived lipid bilayer. Two virus proteins are integrated in the lipid membrane, the envelope (E) protein and the membrane (M) protein. The (+)ssRNA genome is approximately 11 kb in length and contains one large open reading frame (ORF) which is flanked by 5' and 3' untranslated regions (UTR). The ORF encodes a single polyprotein that is cleaved by viral and cellular proteases into three structural proteins (C, prM, E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) (Lindenbach and Rice, 2003) . In general, wild-type strains of TBEV (i.e. field isolates) are neuropathogenic following either intracranial or peripheral inoculation and in the mouse model this usually results in lethal infections (Mandl, 2005) . Sequencing of virus genomes and experiments with infectious clones have shown that TBEV neuropathogenicity is determined by mutations in different regions of the flavivirus genome, including those encoding virus proteins and untranslated regions (Hurrelbrink and McMinn, 2003) . However most of the studied TBEV strains were subcultured many times in the laboratory and this is known to cause a shift of the phenotypic and genotypic characteristics of the virus (Dzhivanian et al., 1988; Kaluzová et al., 1994; Romanova et al., 2007) . In the present work we subcultured natural isolates of a non-neuroinvasive low-passage strain 263, either 5 times in mice or in parallel once at 40°C in PS cells, producing strains 263-m5 and 263-TR both of which proved to be more neuropathogenic in mice than the original 263 strain. As we shall argue later, further characterisation of these strains inferred that the rapid shift in virus neuropathogenicity that occurred during adaptation of the tick isolate to mammalian cells was due to the selection of virus quasispecies rather than to the emergence of new mutations. One of two identified mutations (NS3 A→S 73 ) mapped in close proximity to the NS2B-NS3 protease active site and may determine the neuroor non-neuropathogenicity of the TBEV 263 strain. We propose that the non-virulent variants, found in the natural environment, are highly adapted to ticks and therefore might play an important role in sustaining human population immunity to TBEV by causing sub-clinical infections.
Results and discussion
It has been recognized since the 1960s, that TBEV isolated from field-caught ticks contains a heterogeneous population of variants that produce a range of plaque sizes, express temperature-sensitivity, and neuroinvasiveness (Mayer and Kožuch, 1969) . Subclinical TBE infections were reported in monkeys and hamsters, but not in laboratory mice (Simon et al., 1966) . It was therefore postulated that the wild-type strains of TBEV, i.e. those isolated from the environment, are neuropathogenic following either intracranial or peripheral inoculation leading to lethal infections in mice (Mandl, 2005) .
However, four strains (263, 274, 280, and 282) isolated from ticks in the Czech Republic are, a) completely non-neuroinvasive in laboratory mice, b) temperature-sensitive, c) turbid small plaque producers and d) slow growers in cell culture (Kopecký et al., 1991; Růžek et al., 2006) . In this work we propagated strain 263 through suckling-mouse brains 5 times to study the stability of the non-neuroinvasive phenotype. After each passage, the basic biological properties of the virus (designated 263-m1, 263-m2, 263-m3, 263-m4 and 263-m5) were investigated, viz. temperaturesensitivity, plaque morphology and neuroinvasiveness. Reversion of temperature-sensitivity began to occur after the first passage and by the fifth passage, the titre of the 263-m5 recovered in cell cultures, was virtually the same at permissive and non-permissive temperatures (Fig. 1A) . After the 3rd mouse passage, there was a mixture of small plaques (b1 mm in diameter) with a small proportion of large plaques (4-5 mm in diameter) but by the 5th passage in mice large plaques formed the predominant population (Fig. 1A) . Similarly, neuroinvasiveness increased continuously with serial passage (Fig. 1B) , and neuroinvasiveness of 263-m5 was virtually identical to that of the virulent Czech strain Hypr.
Independently of the serial passages in mice, the original temperature-sensitive virus (strain 263) was subcultured once at the non-permissive temperature (40°C). This resulted in the selection of a temperature-resistant (263-TR) variant that produced titres at either 37°C or 40°C, differing by less than 10% pfu/ml and in contrast to the parental virus, was highly neuroinvasive for adult laboratory mice (Fig. 1B) .
Whole genome sequence analysis revealed that 263-m5 and 263-TR were identical with each other at the amino acid level and differed from the original 263 isolate by two mutations that mapped at amino acid positions 24 and 73 of the NS2B and NS3 proteins respectively. To evaluate the significance of these substitutions a comparative alignment was constructed for the NS2B-NS3 region of all available flaviviruses. The NS3 protein in complex with the 47-amino acid central hydrophilic region of the NS2B protein functions as a serine protease responsible for the cleavage of virus polyprotein (Erbel et al., 2006) . Alignment of 263 with other tick-borne flaviviruses revealed that 263-m5 and 263-TR displayed the "wild-type" TBEV genotype in relation to the NS2B S 24 and NS3 A 73 whereas NS2B P 24 and NS3 Ser 73 were unique amino acid substitutions of the non-neuroinvasive strain 263 ( Fig. 2A) . Mapping these mutations onto the available three-dimensional structure of the West Nile virus (WNV) serine protease complex NS2B-NS3 (Erbel et al., 2006) revealed that the conserved hydrophobic A 73 (wild-type) of NS3 was substituted by hydrophilic S 73 (of 263 virus). The NS3 A→S 73 mutation (equivalent to the Gly 70 of WNV) was localized in close proximity to a catalytic site that is formed by direct interaction of the catalytic triad H 51 D 75 S 135 of the NS3 protein with a loop produced by amino acids D 82 F 85 of the NS2B protein (WNV enumeration). The A 73 in the NS3 protein (TBEV enumeration) is absolutely conserved between all tick-borne and no-known vector flaviviruses (Fig. 2B) . This might cause the reduction of NS2B-NS3 protease activity and also lead to the attenuation of the 263 strain. The second mutation Ser 24 →Pro 24 , which is nonconserved, mapped in the hydrophobic region of the NS2B protein, outside the central hydrophilic domain which provides co-factor protease activity. It is unlikely that the Ser 24 →Pro 24 substitution directly influences the protease activity although it could cause instability of the NS2B-NS3 complex, especially at the non-permissive temperature. It is possible that the second mutation Ser 24 →Pro 24 of the 263 strain is "compensatory", i.e. without the first mutation, A→S 73 may not be functional.
Future experiments using infectious clones of TBEV may clarify these interpretations.
In comparison with strain 263, both 263-m5 and 263-TR, possessed a virtually identical large deletion in the proximal region of the 3'UTR (Fig. 3) . The proximal 3'UTR domain was previously described as a variable domain (V3'UTR), located between the stop codon and terminal ∼320-nucleotide region, conserved between tick-borne flaviviruses (C3'UTR or core). Neither spontaneous nor engineered deletions in the hypervariable domain affected virus pathogenicity in cell culture or mice (Mandl et al., 1998) . One can therefore propose that this deletion did not contribute significantly to the pathogenetic properties of the virus.
Interestingly, despite the fact that both 263-TR and 263-m5 were derived independently, they displayed two identical amino acid differences and an almost identical deletion in the 3'UTR strongly suggesting that the selection of virus variants from a quasispecies population in strain 263, rather than the emergence of new mutants, occurred during laboratory passage of the parent virus in mice or PS cells. The likelihood of three identical independent mutations/deletions appearing in two distinct viruses after serial passage in mice or a single passage at a nonpermissive temperature is much lower than the possibility of the selection of the same variant from quasispecies populations. It seems likely that a "wild-type" neuroinvasive (virulent) variant with NS2B-Ser 24 /NS3-Ala 73 was present as a minor quasispecies component within the non-neuroinvasive 263 virus population. One could then imagine that changing the host, from invertebrate (tick) to mammalian (mice or porcine kidney cells) resulted in preferential selection of the neuroinvasive variant. These two mutations in the NS2B and NS3 proteins were previously described in strain 263 amongst a total of 12 non-conserved unique amino acids, in comparison with two other neuroinvasive strains of Western European TBEV (Wallner et al., 1996) .
In order to understand the difference in neuroinvasiveness between the neuroinvasive and non-neuroinvasive strains, we examined the distribution of these viruses in the tissues of adult mice at various time intervals. After subcutaneous inoculation of 100 pfu of strain 263, no virus was detected in the blood, or in any of the examined lymph nodes, spleen or brain at any of the monitored time points. However, the subcutaneous inoculation of 263-TR or 263-m5 led to efficient replication in all these organs (data not shown). The results suggest that attenuation is based on the inability of the virus to replicate in extraneural tissues and thus the virus is unable to induce viremia or to gain access to the central nervous system. Nevertheless, although the replication of strain 263 is restricted, the cellular and humoral, specific and nonspecific immune mechanisms are markedly activated in the murine host (J. Salát, unpublished results). A delay in virus spread from the site of inoculation is likely to attenuate neuroinvasiveness by allowing time for the host immune system to eliminate the infection (Hurrelbrink and McMinn, 2003) . Virus transmission between ticks co-feeding on the same host in the absence of viremia was postulated to be the main mechanism of TBEV circulation in natural foci implying that viremia is a product, rather than a prerequisite, of efficient TBEV transmission (Labuda et al., 1997) . TBEV can also be transmitted transovarially (Benda, 1958) and trans-sexually (Chunikhin et al., 1983) . All of these transmission mechanisms suggest that most of the TBEV life-cycle is spent in ticks, rather than in mammalian hosts. A number of publications have shown that after mammalto-tick transmission, a rapid shift in the phenotypic characteristics of TBEV occurs (Dzhivanian et al., 1988; Labuda et al., 1994; Kaluzová et al., 1994; Romanova et al., 2007) . Serial passage of TBEV in Hyalomma plumbeum noticeably decreased the virulence for laboratory mice whereas subsequent virus passage through mouse brains led to restoration of the virulent phenotype (Dzhivanian et al., 1988) . Similarly, passaging of TBEV through the salivary glands of Ixodes ricinus led to a reduction of neuroinvasiveness that was subsequently restored when the attenuated virus was passaged through mouse brains . The selection, during serial passage, of pre-existing quasispecies was postulated to be the explanation for the rapid shift of virus phenotypic characteristics. Moreover, mutations in the E glycoprotein were thought to be responsible for the adaptation of TBEV to ticks or mammals Romanova et al., 2007) . However in the present work we have demonstrated that selection of the more virulent strains 263-m5 and 263-TR occurred as the result of mutations in regions of the genome other than the E glycoprotein. Interestingly, with hostrange mutants containing mutations either in the E protein Romanova et al., 2007) or the NS2B/NS3 protein (demonstrated here), viruses isolated from ticks, characteristically displayed reduced plaque size, reduced thermostability and reduced neuroinvasiveness. In contrast, strains adapted to mammals were rapidly-growing viruses, with large plaque morphology, increased thermostability and increased neuroinvasiveness. Whether or not virus growth characteristics rather than specificity of mutations (within E or NS2B/NS3) determine the host-range selection, remains to be determined.
The results imply that naturally occurring non-neuroinvasive TBEV strains circulate among virulent TBEV strains between ticks and can induce sub-clinical infections in humans and wild species. As revealed by the serological investigations, the ratio of manifest to unapparent human TBEV infections is approximately 2:3 (Luňáčková et al., 2003) indicating that a significant proportion of the human population in the Czech Republic may have been infected by attenuated non-neuroinvasive TBEV strains that thus sustain a high level of population immunity.
As far as we are aware, this is the first study to demonstrate, that virulent and attenuated viruses may co-exist as quasispecies in the same TBEV population and rapid conversion of neurovirulence during virus tick/mammal adaptation is mediated by selection from the quasispecies population rather than random mutagenesis during virus passage in the laboratory. Secondly, we have demonstrated that host-range adaptation is associated with mutations in the non-structural NS2B/NS3 proteins, with one mutation mapping close to the catalytic site of the virus serine protease. This contrasts with reports which identified host-range selection of variants with mutations in the E glycoprotein. These results extend our understanding of the molecular basis of TBEV circulation in natural foci and the induction of population immunity in endemic regions.
Material and methods

Viruses and cells
The Czech TBEV strain Hypr (accession number U39292) was used as a control. Hypr was originally isolated from the blood of a 10-year-old child diagnosed with tick-borne encephalitis in 1953 and has been propagated through numerous mouse brain passages. The complete genomic sequence (accession number U27491) of the studied strain 263 isolated from I. ricinus collected by flagging in 1987 (Kopecký et al., 1991; Růžek et al., 2006) was described previously (Wallner et al., 1996) . The virus was propagated twice in suckling mice. Porcine kidney stable (PS) cells were grown at 37°C in L-15 medium supplemented with 3% newborn calf serum and 1% mixture of Penicillin and Streptomycin (Sigma). Plaque morphology and virus titres were assayed on PS cell monolayers, as described previously (De Madrid and Porterfield, 1969) .
Neuroinvasiveness testing
To estimate neuroinvasiveness, groups of 10 adult ICR mice (females, body weight 20-25 g; AnLab Prague, Czech Republic) were inoculated subcutaneously with 100 pfu of virus. Survival of mice was observed daily for a period of 28 days p.i.
Passaging of the virus in mouse brains
A group of suckling ICR mice (5 to 6 days old) was intracerebrally inoculated with 10 4 pfu of virus per mouse. During the acute stage of infection with apparent neurological signs of disease, the brains were removed, weighed, homogenized and prepared as a 20% suspension (w/v) in L-15 medium containing 3% newborn calf serum. Each homogenate was clarified by centrifugation at 5000 ×g and the supernatant medium was used for the inoculation of the next group of mice. After each passage, we investigated the basic biological properties of the virus: temperature-sensitivity, the character of the plaques in cell culture and neuroinvasiveness.
Virus growth in mouse tissues
Groups of adult ICR mice (females, body weight 20-25 g) were inoculated subcutaneously with 100 pfu of virus into the scruff of the neck. At the given time points after inoculation, 3 mice of each group were anesthetized and humanely killed. Specimens of the blood, lymph nodes (superficial cervical, axillary, brachial, and inguinal lymph nodes), spleen, and brain were collected. Organs were individually weighed and homogenized with a mortar and pestle, and prepared as 10 or 20% suspensions (w/v) in L-15 medium containing 3% newborn calf serum. The suspensions were clarified by centrifugation at 10,000 ×g and supernatant fluids were titrated by plaque assay on PS cells. The detection thresholds were for specimens of blood 1.7 log 10 pfu/ml, for 20% suspensions (brain, spleen) 2.4 log 10 pfu/g, and for 10% suspensions (lymph nodes) 2.7 log 10 pfu/g.
Sequence analysis
Nucleic acid sequences were determined by direct sequencing of both strands of PCR products with the automated Beckman CEQ 2000 DNA Analysis System (Beckman Coulter). The results of the sequence analysis were processed using Chromas, version 1.45 (http://www.techlysium.com.au/chromas.html). The nucleotide and deduced amino acid sequences were analyzed using BioEdit Sequence Alignment Editor, version 5.0.6. (http:// www.mbio.nscu.edu/BioEdit/bioedit.html) and GeneDoc, version 2.6.002 (http://www.psc.edu/biomed/genedoc) and aligned with other available genomic sequences of TBEV strains. Alignments are available on request.
3D structure analysis of NS3 protein
The predicted three-dimensional structures of NS3 protein (2ijo.pdb) and the superimposition of mutations were produced using PYMOL facilities available at http://pymol.sourceforge. net/.
